CrossAssetDataThe Company File
···
PAYS

Paysign, Inc.

Paysign, Inc. is classed by the SEC under Services-Business Services, NEC (industry code 7389), based in Henderson, NV. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $82 million and a profit of $8 million (its filed statements).

Marketplace business Services-Business Services, NEC Henderson, NV filings since 2010 9 of 9 filed
Ask the desk about PAYS → Compare PAYS with DVLT → Price chart on TradingView ↗ Full EDGAR file ↗ Watch PAYS →

Sector peers: DVLTPOWWRGPAMWL

6.7/10headline grade
vs its business-model standard
5.1/10past 5.9/10present 8.3/10future

Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a marketplace business: prior from its industry code (SEC 7389, Services-Business Services, NEC); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.

The grade, in three tenses

Headline 6.7 out of ten, 9 of 9 metrics filed: past 5.1 out of ten, present 5.9 out of ten, future 8.3 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.

The nine metrics

  • Surviving crises (past): 2.1 out of ten. 8 warning events since 2017; the latest 2025-06-06. 21st percentile among 105 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Track record (past): 7.7 out of ten. +27.7% a year over 6 filed years; profitable in 4 of 6. 77th percentile among 99 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Shareholder treatment (past): 3.5 out of ten. Share count grew 1.5% a year. 2% of cash flow returned. Insiders: 20 sales, 0 purchases. 35th percentile among 70 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Financial health (present): 4.2 out of ten. ROE 16%: 16¢ of profit per shareholder dollar. Leverage 82%: owes 82¢ per asset dollar. 42nd percentile among 98 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Industry position (present): 5.8 out of ten. top 42% of 101 in its family; net margin 9.2%. 58th percentile among 101 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Leadership (present): 8.7 out of ten. top 13% of 67 in its family for leadership; chief executive since 2010. 87th percentile among 67 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
  • Room to expand (future): 8.6 out of ten. top 14% of 99 in its family for room to expand. 86th percentile among 99 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Growth drivers (future): 9.0 out of ten. top 10% of 99 in its family for growth drivers. 90th percentile among 99 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Expectations vs reality (future): 6.4 out of ten. top 36% of 93 in its family for expectations against reality. 64th percentile among 93 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).

The filing record

Newest annual report: Form 10-K filed 2026-03-25 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-06 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-05 (on EDGAR). Newest filing: Form 4, 2026-09-17. Filings on record since 2010. Read from EDGAR 2026-10-12.

Where the revenue comes from

Product and service lines in fiscal 2025: Plasma Industry 55%, Pharma Industry 41%, Other Revenue 3%, Breakage Revenue 1%. As tagged in its annual report (Form 10-K, filed 2026-03-25).

Who runs it

Newcomer, Mark (CEO); Baker, Jeffery Bradford (Chief Financial Officer); Ngo, Michael C (Chief Innovation Officer); Cunningham, Bradley Kramer (Chief Technology Officer); Lanford, Matthew Louis (Chief Payments Officer); Strobo, Robert (Chief Legal Officer); Herman, Joan M (EVP, Operations); Turner, Matthew Baker (PRES., PATIENT AFFORDABILITY); Henry, Daniel R (director); Mina, Bruce A (director); and 2 more. 12 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.

This file: Overview · Past · Present · Future · Filings · every company on file

Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.